WOONSOCKET – CVS Pharmacy Inc., the subsidiary of CVS Health Corp., has agreed to pay $1.5 million to resolve a federal investigation into certain stores on Long Island, N.Y., that failed to report the loss or theft of controlled substances, including the opioid hydrocodone, the U.S. Department of Justice announced Thursday. “The failure to promptly…
Want More Free?
To access 2 more articles, please log in or register for free.
Registered users get access to a limited number of free articles every month.